Key Takeaways Hims & Hers' stock rose 64.1% in six months, beating industry peers and major market benchmarks.HIMS' Q2 results showed higher online revenue per subscriber, offset by weaker wholesale performance.HIMS is expanding into Europe and Canada, backed by an $870 million notes offering and an AI-driven strategy.Hims & Hers Health, Inc.’s (HIMS) investors have been experiencing some short-term gains from the stock lately, despite its bumpy ride over recent months. The San Francisco, CA-based health an ...